Assessments
Four business people walking up stairs
First Joint Clinical Assessment (JCA) Report Published: Implications for Evidence Strategy in Europe
Explore the key findings from the first Joint Clinical Assessment (JCA) report and what they mean for comparator selection, evidence generation, and submission strategy across Europe.
Read More
Articles
Man standing and looking at tablet
How patient services best-in-class benchmarking improves patient access
Discover how patient services benchmarking helps identify access barriers, improve operations, and optimize investment to enhance therapy initiation, adherence, and patient outcomes.
Read More
Articles
Business people talking and working at table
HUB and specialty pharmacy optimization support
Discover how patient services benchmarking helps identify access barriers, improve operations, and optimize investment to enhance therapy initiation, adherence, and patient outcomes.
Read More
Business people sitting and listening to presenter
2026 patient services insights and innovation survey
Read our report insights to explore the priorities, investments, and performance drivers influencing patient services today.
Read More
Articles
Two people leaning over table and tablet talking business
Spain has just redrawn the rules of health technology assessment
Explore how Spain’s new health technology assessment framework is reshaping market access, evidence strategy, pricing decisions and lifecycle planning.
Read More
Articles
Three business people sitting at table working
Are you JCA ready? Practical steps for pharma teams
Learn the key steps to JCA readiness. Anticipate PICO scenarios, align evidence with EU HTA, and accelerate market access success.
Read More
Articles
Woman holding an elderly man's hand
What the National Cancer Plan for England signals for oncology innovation and access
Explore how the National Cancer Plan for England is reshaping oncology access expectations, regulatory timelines, and HTA and JCA planning.
Read More
Case Study
Businessman standing at conference table full of people in office presenting
How to use early modeling to assess price potential and HTA strategy
Learn how early modeling supports pricing strategy, HTA planning, cost-effectiveness assessment, and evidence generation to strengthen market access decision-making.
Read More
Articles
Man presenting plans on paper to two other business people
Why NICE’s new cost-effectiveness threshold matters for pharmaceutical access in the UK
NICE updates its cost-effectiveness threshold. Discover the implications of this change for the UK HTA, patient access, and pricing strategy.
Read More